Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;10(1):36.
doi: 10.1186/s40662-023-00354-1.

Rates of infectious keratitis and other ocular surface adverse events in corneal cross-linking for keratoconus and corneal ectasias performed in an office-based setting: a retrospective cohort study

Affiliations

Rates of infectious keratitis and other ocular surface adverse events in corneal cross-linking for keratoconus and corneal ectasias performed in an office-based setting: a retrospective cohort study

Farhad Hafezi et al. Eye Vis (Lond). .

Erratum in

Abstract

Background: This study aimed to compare the complication rates of epithelium-off corneal cross-linking (epi-off CXL) performed in an office-based setting with those of epi-off CXL performed in an operating room.

Methods: A retrospective cohort study, comprising 501 consecutive epi-off CXL procedures, performed in a non-sterile procedure room without laminar flow ventilation at the ELZA Institute in Zurich, Switzerland, between November 2015 and October 2021, was conducted.

Results: No cases of postoperative infectious keratitis were observed, while sterile infiltrates occurred in 10 out of 501 (2.00%) patients, all of whom responded well to topical steroid therapy. Delayed epithelialization (> 7 days) occurred in 14 out of 501 (2.79%) patients. No other adverse events were noted.

Conclusions: Office-based epi-off CXL does not appear to be associated with an increased risk of complications when compared to operating room settings.

Keywords: Cornea; Corneal cross-linking; Epithelium-off; Infectious keratitis; Keratoconus; Office-based; Slit lamp; Sterile infiltrates.

PubMed Disclaimer

Conflict of interest statement

NH is CEO of EMAGine AG, a company producing a CXL device. FH holds a patent on a UV light source (PCT/CH 2012/000090) and is CSO of EMAGine AG. FH is an editorial board member of Eye and Vision. The other authors have no proprietary or commercial interest in any of the materials discussed in this article.

Similar articles

References

    1. Randleman JB, Khandelwal SS, Hafezi F. Corneal cross-linking. Surv Ophthalmol. 2015;60(6):509–523. doi: 10.1016/j.survophthal.2015.04.002. - DOI - PubMed
    1. Belin MW, Lim L, Rajpal RK, Hafezi F, Gomes JAP, Cochener B. Corneal cross-linking: current USA status: report from the cornea society. Cornea. 2018;37(10):1218–1225. doi: 10.1097/ICO.0000000000001707. - DOI - PubMed
    1. Hafezi F, Richoz O, Torres-Netto EA, Hillen M, Hafezi NL. Corneal cross-linking at the slit lamp. J Refract Surg. 2021;37(2):78–82. doi: 10.3928/1081597X-20201123-02. - DOI - PubMed
    1. Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol. 2004;80:15–21. - PubMed
    1. Tabibian D, Mazzotta C, Hafezi F. PACK-CXL: corneal cross-linking in infectious keratitis. Eye Vis (Lond) 2016;3:11. doi: 10.1186/s40662-016-0042-x. - DOI - PMC - PubMed

LinkOut - more resources